PIROUETTE PHARMA INC. — Form D

PIROUETTE PHARMA INC. of PORTSMOUTH, NH, a company, filed a Form D exempt-offering notice with the SEC on 2025-04-01. The offering totals $3.5M, of which $2.4M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (16)

NameRoleLocation
CONOR CULLINANEDirectorPORTSMOUTH, NH
MATTHEW KANEDirectorPORTSMOUTH, NH
Parinaz MotamedyDirectorCambridge, MA
JOSEPH NEMMERSDirectorPORTSMOUTH, NH
CONOR CULLINANEExecutive OfficerPORTSMOUTH, NH
MATTHEW KANEExecutive OfficerPORTSMOUTH, NH
ELIJAH KAPASExecutive OfficerPORTSMOUTH, NH
CONOR CULLINANEPromoterPORTSMOUTH, NH
MATTHEW KANEPromoterPORTSMOUTH, NH
ELIJAH KAPASPromoterPORTSMOUTH, NH
Arunas ChesonisDirectorBoston, MA
Arunas ChesonisExecutive OfficerBoston, MA
Arunas ChesonisPromoterBoston, MA
ELIJAH KAPASDirectorPORTSMOUTH, NH
JOSEPH NEMMERSExecutive OfficerPORTSMOUTH, NH
JOSEPH NEMMERSPromoterPORTSMOUTH, NH

Other filings by this issuer (4)

FiledFormOfferingSold
2026-03-18D$6.0M$1.1M
2022-06-15D$15.0M$2.5M
2021-09-02D$10.6M$7.0M
2021-07-06D$1.3M$1.0M

More